INOTIV INC (NOTV)
US45783Q1004 - Common Stock
NOTV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 57 industry peers in the Life Sciences Tools & Services industry. NOTV may be in some trouble as it scores bad on both profitability and health. NOTV is valied quite expensively at the moment, while it does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year NOTV has reported negative net income.
In the past year NOTV has reported a negative cash flow from operations.
NOTV had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: NOTV reported negative operating cash flow in multiple years.
1.2 Ratios
The Return On Assets of NOTV (-13.88%) is comparable to the rest of the industry.
Looking at the Return On Equity, with a value of -63.60%, NOTV is doing worse than 70.18% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.88% | ||
| ROE | -63.6% | ||
| ROIC | N/A |
ROA(3y)-20.38%
ROA(5y)-13.08%
ROE(3y)-65.39%
ROE(5y)-49.53%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 22.65%, NOTV is doing worse than 78.95% of the companies in the same industry.
NOTV's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for NOTV so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.65% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.4%
GM growth 5Y-6.74%
2. Health
2.1 Basic Checks
NOTV does not have a ROIC to compare to the WACC, probably because it is not profitable.
NOTV has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NOTV has been increased compared to 5 years ago.
NOTV has a worse debt/assets ratio than last year.
2.2 Solvency
NOTV has an Altman-Z score of -0.42. This is a bad value and indicates that NOTV is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.42, NOTV is doing worse than 78.95% of the companies in the same industry.
NOTV has a Debt/Equity ratio of 2.29. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.29, NOTV is not doing good in the industry: 87.72% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.29 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.42 |
ROIC/WACCN/A
WACC9.28%
2.3 Liquidity
A Current Ratio of 1.37 indicates that NOTV should not have too much problems paying its short term obligations.
With a Current ratio value of 1.37, NOTV is not doing good in the industry: 78.95% of the companies in the same industry are doing better.
A Quick Ratio of 1.22 indicates that NOTV should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.22, NOTV is doing worse than 68.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.22 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 11.92% over the past year.
Looking at the last year, NOTV shows a very negative growth in Revenue. The Revenue has decreased by -14.29% in the last year.
NOTV shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 62.28% yearly.
EPS 1Y (TTM)11.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.89%
Revenue 1Y (TTM)-14.29%
Revenue growth 3Y76.27%
Revenue growth 5Y62.28%
Sales Q2Q%-7.33%
3.2 Future
NOTV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.61% yearly.
Based on estimates for the next years, NOTV will show a quite strong growth in Revenue. The Revenue will grow by 14.23% on average per year.
EPS Next Y23.92%
EPS Next 2Y20.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year8.01%
Revenue Next 2Y6.86%
Revenue Next 3Y17.67%
Revenue Next 5Y14.23%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
NOTV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NOTV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NOTV is valued a bit cheaper than the industry average as 63.16% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 80.56 |
4.3 Compensation for Growth
NOTV's earnings are expected to grow with 20.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.61%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NOTV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
INOTIV INC
NASDAQ:NOTV (12/20/2024, 8:00:01 PM)
Premarket: 4.08 0 (0%)4.08
+0.24 (+6.25%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners17.18%
Inst Owner Change-19.89%
Ins Owners8.84%
Ins Owner Change23.36%
Market Cap106.16M
Analysts80
Price Target5.44 (33.33%)
Short Float %6.34%
Short Ratio2.25
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)32.67%
Min EPS beat(2)-17.41%
Max EPS beat(2)82.76%
EPS beat(4)2
Avg EPS beat(4)-35.28%
Min EPS beat(4)-237.69%
Max EPS beat(4)82.76%
EPS beat(8)4
Avg EPS beat(8)-16.57%
EPS beat(12)8
Avg EPS beat(12)135.64%
EPS beat(16)9
Avg EPS beat(16)91.18%
Revenue beat(2)1
Avg Revenue beat(2)-3.31%
Min Revenue beat(2)-15.95%
Max Revenue beat(2)9.34%
Revenue beat(4)1
Avg Revenue beat(4)-4.17%
Min Revenue beat(4)-15.95%
Max Revenue beat(4)9.34%
Revenue beat(8)4
Avg Revenue beat(8)-0.35%
Revenue beat(12)7
Avg Revenue beat(12)3.39%
Revenue beat(16)10
Avg Revenue beat(16)4.26%
PT rev (1m)0%
PT rev (3m)14.28%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.05%
EPS NY rev (3m)-3.05%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.63%
Revenue NY rev (3m)-0.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.22 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.62 | ||
| P/tB | N/A | ||
| EV/EBITDA | 80.56 |
EPS(TTM)-3.62
EYN/A
EPS(NY)-2.75
Fwd EYN/A
FCF(TTM)-1.12
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS18.86
BVpS6.55
TBVpS-7.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -13.88% | ||
| ROE | -63.6% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 22.65% | ||
| FCFM | N/A |
ROA(3y)-20.38%
ROA(5y)-13.08%
ROE(3y)-65.39%
ROE(5y)-49.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.4%
GM growth 5Y-6.74%
F-Score1
Asset Turnover0.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.29 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 65.69 | ||
| Cap/Depr | 39.06% | ||
| Cap/Sales | 4.55% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.37 | ||
| Quick Ratio | 1.22 | ||
| Altman-Z | -0.42 |
F-Score1
WACC9.28%
ROIC/WACCN/A
Cap/Depr(3y)54.31%
Cap/Depr(5y)102.83%
Cap/Sales(3y)5.33%
Cap/Sales(5y)8.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.89%
EPS Next Y23.92%
EPS Next 2Y20.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-14.29%
Revenue growth 3Y76.27%
Revenue growth 5Y62.28%
Sales Q2Q%-7.33%
Revenue Next Year8.01%
Revenue Next 2Y6.86%
Revenue Next 3Y17.67%
Revenue Next 5Y14.23%
EBIT growth 1Y-2005.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year548.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-7761.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-124.41%
OCF growth 3YN/A
OCF growth 5YN/A